| |
|
|
|
Applied DNA Sciences Inc.  
|
|
4.14 0.32 (0.08%) |
11-20 16:00 |
|
Open: |
3.84 |
Pre close: |
3.82 |
Target:
|
15.86
|
|
High: |
4.28 |
Low: |
3.84 |
Resistance:
|
13.58
19.69
|
|
Volume: |
584,690 |
Market Cap: |
14M |
Support:
|
3.70
3.08
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
4.28
 |
MACD |
MACD(12,26):
|
-1.23 |
|
MA(20): |
6.90 |
Signal(12,26,9): |
-0.93 |
|
MA(100): |
11.33 |
Stochastic Oscillator |
%K(14,3):
|
1.27  |
|
MA(250): |
19.54 |
%D(3): |
1.43 |
|
Average Volume(K) |
3-Month: |
44242
|
52-Week |
High:
|
48.40 |
|
10-Days: |
249318 |
Low: |
3.70 |
|
RSI |
RSI(14):
|
43.44 |
Change(%): |
-90.6 |
|
Financials, Statistics and Valuation |
|
EPS |
-12.885 |
Return on Equity (ttm) |
-1713.0 |
Shares Out. (M) |
1.20 |
|
EPS Est. Current Year |
-0.440 |
Return on Assets (ttm) |
-139.8 |
Shares Float (M) |
0.69 |
|
EPS Est. Next Year |
-0.230 |
PEG Ratio |
0.00 |
% Held by Insiders |
23.39 |
|
EPS Est. Next Quarter |
-0.100 |
Qtrly Rev. Growth |
102.0 |
% Held by Institutions |
5.05 |
|
Forward EPS |
-0.140 |
Gross Profit (p.s.) |
2.250 |
Shares Short (K) |
36 |
|
Book Value (p.s.) |
-1.870 |
EBITDA (p.s.) |
-8.567 |
P/E |
-0.32 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
-2.21 |
|
Profit Margin |
-221.40 |
Operating Cash Flow
(M) |
-7.59 |
P/S |
0.71 |
|
Operating Margin |
-218.38 |
Levered Free Cash Flow
(M) |
-4.23 |
P/CF |
-0.65 |
|
|
|
|
|
|
